The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

The government of the state where I grew up does not trust and support medical professionals, so I won't stick around, writes ...

Robert Malone, a member of RFK Jr.'s new CDC vaccine advisory committee, is spreading myths about Amish immunity to ...

Variant NB.1.8.1 accounted for 0% of U.S. cases in April. By mid-June, it was estimated to be the cause of around 37% of ...

Measles cases in the U.S. are at their highest in three decades The U.S. is having its worst year for measles spread in more ...

The Centers for Disease Control and Prevention says the U.S. is currently experiencing its worst measles outbreak in more ...

CureVac shares skyrocketed 35% Thursday when the biotech firm agreed to be bought by COVID-19 vaccine maker BioNTech in an all-stock deal valued at about $1.25 billion.

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60. Health ...

RSV, meningococcal, and chikungunya vaccine recommendations from the previous ACIP panel are now official policy.

Doctors groups and public health organizations are suing the U.S. government over the decision to stop recommending COVID-19 ...

As we get back to summer travel, cookouts, and time with friends and family, COVID-19 is still something to watch out for.